Name: 16th World Oncologists Congress
Start: 2019-12-09
End: 2019-12-11
Location: Baltimore

- Quick Links -

Previous Conference Performers / Professionals From Around The Globe

Kathleen Kenney-Riley

Mercy College, USA
USA

Jianyu Rao

University of California, USA
USA

Robert W. Tygenhof

Integrative Medical Group of Irvine, USA
USA

Dr DanCMartin

Obstetrician-gynecologist in Memphis, Tennessee, USA
USA

Elliot M Levine

Obstetrician-gynecologist in Chicago, Illinois, USA
USA

George Peery

Dean University of Texas USA, USA
USA

Kwong-Kwok-Wong

University of Texas, USA
USA

Brian Keevil

University Hospital of South Manchester , UK
UK

Alex Ferenczy

McGill University, Canada
Canada

Moustafa K Eissa

Cyberjaya University College of Medical Sciences, Malaysia
Malaysia

Franco Maria Buonaguro

Istituto Nazionale Tumori, Italy
Italy

Donna Vine

University of Alberta, Canada
Canada

Tracks & Key Topics

Tracks

Academic Key Topics

Business Key Topics

About Conference

EuroScicon welcomes you to attend the 16th World Oncologists Congress, focus on Current Advancements and its Applications in cancer therapies and other issues in cancer research from December 9-10, 2019 in Baltimore, USA. The Oncologist Congress theme will be addressing regarding “Exploration of Building Blocks for Advancing Cancer Research " which will provide an international platform for discussion of present and future challenges in Oncology, Cancer Screening, continuing education and expertise meeting. World’s foremost health clinicians, Oncologists, Immunologists, educators and researchers will present leading-edge and practical operations based upon truly accepted evidence and will initiate new and originate research.

What’s New

Oncologists Congress 2019 includes international attendee workshops, lectures and symposia, including accessible registration area, and to ease up and delight. Oncology professional can join the EuroSciCon as an international member to receive discounts on registration. So, come and accompany prominent experts and gather professionals from December 9-10, 2019 in Baltimore, USA to keep up with the quickly accelerate pace of differences that is already having an impact on the field of Oncology, and will rectify eventually in this cancer conferences.

Benefits for Conference Attendees

For Researchers & Professors:

Speaker Presentations
Poster Display
Symposium hosting
Workshop organizing

For Associations, Universities & Societies:

Association Partnering
Collaboration proposals
Academic Partnering
Group Participation

For Students & Research Scholars:

Poster Competition
Young Researcher Forum
Group Registrations

For Business Delegates:

Speaker Presentations
Symposium hosting
Book Launch event
Audience participation

For Companies:

Exhibitor Booths
Sponsorships opportunities
Product launch
Workshop organizing
Scientific Partnering
B2B interaction with clients

Why to visit the Oncologists Congress 2019?

Oncologists Congress 2019 will congregate the unified spectrum of the Cancer research, regarding its prevention, analysis & cure, treatment, side effects of prescription, supportive care, quality-of-life, and survivorship issues in the field of cancer. It will include the use of technologies, both in the diagnosis and treatment against cancer. The oncologists congress 2019 will provide clinicians and researchers with a platform to publicize their subjective experiences to a huge public as well as to know interesting cases regarding Cancer come across by colleagues all over the world.

About city

Baltimore is the largest city in the State of Maryland, and the 30th-most populous city in the United States. Baltimore was established by the Constitution of Maryland and is an independent city that is not part of any county. Founded in 1729, Baltimore is the second-largest seaport in the Mid-Atlantic. Baltimore exhibits examples from each period of architecture over more than two centuries. It is a historical and contemporary Centre for education, the art, industry, administration, and economy. Baltimore is the home of numerous places of higher learning, both public and private. A proud moment to introduce the 16th World Oncologists Congress to the Metropolitan area Baltimore, USA.

Target audience

An excellent opportunity to share and gain knowledge , ideas, & researches in the Oncology conferences 2019 on Colorectal Cancer, to understand it and try spreading the prevention which is only possible with the support of all of you, which will be happening in this Oncologists Congress 2019.

Oncologists
Professors
Associate professors
Surgeon
Medical oncologist
Radiation oncologist
Health care professionals
Physician assistants
Oncology nurses
Social workers
Pharmacists
Counselors
Dietitians
Research scholars & students.

Target audience

Oncologists
Professors
Associate professors
Surgeon
Medical oncologist
Radiation oncologist
Health care professionals
Physician assistants
Oncology nurses
Social workers
Pharmacists
Counselors
Dietitians
Research scholars & students.

SESSIONS & TRACKS

Track 1: Oncology

Oncology is a branch of medicine that deals with the preclusion, diagnosis, and treatment of cancer. Distinctive tumours manipulating varied body parts e.g. blood cancer, prostate, lungs, platelets (leukaemia) or different organs carry on in various way are of different evaluations and cell write, react constantly to treatment and have varied arrangement of compelling treatment procedure. A health proficient who practices oncology is an oncologist. Inside oncology there are uncommon sub-claims with distinct that arrangement with various kinds of disease and blood growth composes or blood cancer types. Diagnosis and staging investigation depends on the site and type of malignancy.

Hemato oncology
Pediatric Oncology
Ocular oncology
Psycho-oncology
Nuclear medicine oncology
Pain & Palliative oncology

Track 2: Organ Defined Cancer

Cancers are categorized via type of cell that the tumor cells resemble and are therefore presumed to be the origin of the tumor. Types of cancers are Carcinoma, Sarcoma, Lymphoma and leukemia, Germ cell tumor and Blastoma. These occur in the different organs in the human body. Organ specific cancers specified by the name they occur at the particular organ. The most usual sites of cancer among men are lung, prostate, colon, rectum, stomach and liver. And those for among women include breast, colon, rectum, lung, cervix and stomach.

Breast cancer
Cervix cancer
Head & Neck Cancer
Brain cancer
Thyroid cancer
Skin cancer

Track 3: Cancer Metastasis

Metastasis is a pathogenic agent's spread from an initial site to a site within the host's body. It is generally distinguished from cancer invasion, which is the direct extension and penetration by cancer cells into neigh boring tissues. Cancer can spread from its new site by local spread, lymphatic spread to regional lymph nodes or by hematogenous spread via the blood to distant sites, known as metastasis. If cancer spreads by a hematogenous route, it usually spreads all over the body. At the late stage of cancer metastatic tumours are very common.

Angiogenesis
Epigenetic
Transcoelomic
Lymphatic spread
Hematogenous spread
Canalicular spread
Cancer Biomarkers

Track 4: Cancer Biomarkers

A biomarker is a quantifiable indicator of the severity or presence of some disease state, used in medicine. A cancer biomarker statuses to a constituent or procedure that is reveals the presence of cancer in the body, it may be secreted by the tumour or specific response to the presence of the body. Cancer biomarkers are especially used for the identification of breast cancer. Cancer biomarkers are used for the risk assessment, diagnosis, prognosis and treatment prediction, pharmacokinetics & pharmacodynamics, developing drug targets and surrogate points.

Genetic Biomarkers
Epigentic Biomarkers
Proteomic Biomarkers
Glycomic biomarkers
Imaging Biomarkers

Track 5: Cancer Screening

Cancer screening aims at detection of cancer prior to onset of symptoms. Cancer screening involves blood tests, urine tests, DNA tests and other medical imaging techniques. It benefits for cancer prevention or identification of high risks of developing cancer by early diagnosis. Computed Tomography scan and Magnetic resonance imaging is available for full body screening. Some of the physical screenings are X-ray images, screening mammography, and biopsy.

Breast Cancer screening
Cervical cancer Screening
Prostate cancer screening
Lung cancer screening
Endoscopic Ultrasounds
Sigmoidoscopy / Colonoscopy

Track 6: Cancer Diagnosis and Diagnostics

Cancer Diagnosis and Diagnostics plays an important role throughout the cancer treatment. Diagnosis is done by some of the common tests which include blood test, CT scans, and endoscopy and tissue tests are biopsy. Diagnostics are used to track the size of the tumor, progression of the disease, and patient response to treatment, and modify your treatment. Different types of cancer diagnostic tests are used to Screen at-risk individuals, Monitor treatment capability and disease advancement or reappearance, Predict prognosis and direct treatment, Screen an asymptomatic population for the early detection of cancer.

Cytogenetic
Immunohistochemistry
Targeted Therapy
Cancer immunotherapy
Hormonal Therapy
Angiogenesis inhibitors

Track 7: Cancer Therapy

Removal of the sarcoma without mutilation to the rest of the body is the ideal goal for the cancer treatment. This can be proficient by surgery, but the tendency of cancers to overrun adjacent tissue or to spread to distant sites by microscopic metastasis often parameters its effectiveness. Cancer can be treated by different procedures. The treatment is determined by the location, Phase and evaluation of the cancer. Radiation therapy is used to treat the patient with the ionization radiations which destroys the malignance cells. Chemotherapy, in which anti-cancer drugs are used. Cancer Immunotherapy is a type of treatment which triggers the immune system to treat the cancer. By inhibiting or removing the specific hormones, the cancer growth can be controlled; it can be called as Hormone Therapy in some cancers. Targeted treatment, in which the area of disease can be focused on effortlessly to treat metastatic tumors. Numerous novel Approaches to Cancer Therapeutics are being uncovered in the cancer science and treatment field .Cancer Science and Therapy Conferences are an undertaking to obtain dominance in cancer inquire about field.

Radiation therapy
Chemotherapy
Targeted therapies
Immunotherapy
Hormonal therapy
Angiogenesis inhibitors
Synthetic lethality

Track 8: Tumor Immunology

Tumor Immunology is concerned with understanding the part of the immune system in the development of cancer; the most recognised application is cancer immunotherapy, which exploits the immune system as a treatment for cancer. Cancer immunosurveillance seems to be a significant host defence process that decreases cancer rates through inhibition of carcinogenesis and continuing systematic cellular homeostasis. It has also been recommended to that immunosurveillance primarily functions as a component of a more general process of cancer immunoediting. Tumors may express tumor antigens either TSA (Tumor-specific antigen) or TAA (Tumor-associated antigen) that are recognized by the immune system and may induce an immune response. Immune system would be capable to perform a feature via a ‘bystander effect’ in eradicating chemotherapy-resistant cancer cells.

Tumour Immunogenicity
Antitumor Immune Response
Tumour Elimination
Cancer Immunosurveillance
Cancer Immunology
Chemotherapy

Track 9: Gynaecologic oncology

Gynaecologic oncology is a focused field of medicine that focuses on cancers of the female reproductive system. Gynaecologic Oncology is the study about any cancer that begins in a woman's reproductive organs. The five Gynaecology cancers start in the woman's pelvis at different places. Each cancer is distinctive by its signs, risk factors and in their strategies of prevention. All these five different types of Gynaecology Cancers risk increases with the age. When these cancers were noticed at their early stages, the treatment will be more efficient. The five main types of cancer affect a woman's reproductive organs are ovarian, uterine, cervical, vulvar, and vaginal cancer. All these as a group are known as Gynaecology cancers.

FDA ovarian cancer
Cervical cancer
Vulvar cancer
Ovarian cancer
Uterine cancer
Vaginal cancer

Track 10: Radiation Oncology

Radiation therapy is a therapy which uses ionizing radiation, usually as part of cancer treatment to control or kill malignant cells and normally distributed by a linear accelerator. Radiation oncology is medical subspecialty of oncology concerned with radiotherapy. Radiation oncology concerned with prescribing radiation and is differ from radiology. It is also a mutual association of radiation therapy with surgery, chemotherapy, hormone therapy, immunotherapy or some mixture of the four. Most common malignance types can be treated with radiation therapy in some way. A specialized physician who uses ionizing radiation to treat cancer is known as radiation oncologists.

Metastatic cancer
Breast cancer
Localized cancer
Ovarian cancer
Prostate cancer

Track 11: Chemotherapy

Chemotherapy is the treatment of cancer with one or more chemotherapeutic agents as part of an unvarying regimen. The effectiveness of chemotherapy depends on the type of cancer and the stage. Chemotherapeutic techniques have an array of side-effects that depend on the type of medications used. The aids of chemotherapy sometimes outweigh the danger of adverse effects. Chemotherapy can be in most cases a major adjuvant to clinical therapy and/or radiotherapy. It is most successful against Leukaemia’s. Mechanism-based approaches have also been explored for several decades. About 30 chemotherapeutic drugs are in systematic use in the treatment of cancer till date. All Antitumor drugs may be positioned into one of three classes based on the relationship of the effect to the mitotic cycle of the cell.

Cell cycle active, phase specific
Cell cycle active, phase non-specific
Non-cell cycle active.

Types of Chemotherapy
Combination Chemotherapy
Cancer Chemotherapy Side Effects
Cancer Chemotherapy Resistance

Track 12: Clinical Oncology

Clinical Oncology consists of full spectrum of Nonsurgical Cancers including the Chemotherapy, Radiotherapy, Palliative care and Biological targeted therapy. Clinical oncologists treat Solid tumors with Conventional Radiotherapy, Chemotherapy, Brachytherapy, Biological therapy, Molecular targeted therapy and from time to time with multimodality treatments that consist of the grouping of two or more Anti-cancer therapies. Clinical oncologists define cure by considering a range of factors including tumor type, the site of the tumor, the stage of the disease and the patient’s general health. They then measure the relative assets of different treatments before presenting these to the patient so that an informed decision can be made. The division also includes the study of Cancer staging, Cancer epidemiology, Brachytherapy, Cancer biostatistics etc.

Cancer Cell Mechanisms
Cancer Clinical trials
Cancer Epidemiology
Cancer Biostatistics
Medical Oncology
Interpretive Oncology

Track 13: Surgical Oncology

Surgery is used to analyse stage and treat cancer, and definite cancer-related symptoms. It is the branch of surgery functional to oncology; it focuses on the surgical supervision of tumors, particularly cancerous tumors. Among all Anti-cancer therapies, treatment of Cancer by surgery remains an elementary method for oncology. Surgical oncology is the branch of Oncology that deals with the surgical aspects of cancer including biopsy, cancer staging, and surgical resection of tumors it focuses on the surgical management of tumors, especially cancerous tumors. Surgical oncology is a specialized area of oncology that engages surgeons in the cure and management of cancer. Whether a patient is a candidate for surgery is contingent on factors such as the type, size, location, grade and stage of the tumor, as well as general health factors such as age, physical health and other medical comorbidities. For many patients, surgery will be pooled with other cancer treatments such as chemotherapy, radiation therapy or hormone therapy

Urological Surgery
Gynaecological Surgery
Nuclear Medicine Working
Colon Cancer
Surgery
Rare Abdominal Tumors

Track 14: Cancer Research & Clinical Trials

Cancer research sorts since epidemiology, molecular bioscience to the presentation of medical hearings to assess and relate presentations of the different cancer behaviours. These presentations contain surgery, radiation therapy, chemotherapy, hormone therapy, and immunotherapy and combined treatment modalities such as chemo-radiotherapy. Cancer research comprises a multiplicity of procedures and interdisciplinary series of research. Researchers in cancer investigation may be expert in spaces such as chemistry, biochemistry, molecular biology, physiology, epidemiology, and biomedical engineering. Tumor virology accomplishes the specific infection diseases and malignancy, oncogenes, tumor silencers, oncogenic cofactors, disturbance of natural/versatile resistant reactions, inertness, viral mimicry/robbery of cell administrative qualities, genomic unsteadiness and part of non-coding RNAs in viral pathogenesis. The motivation overdue this examination is to create viral vectors for human growth quality treatment and to advance immunization procedures for treatment of viral-related malignancies. Limited practices are being trailed incorporating hereditary inoculation with recombinant viral vectors in view of Semliki Forest infection, insusceptible checkpoint inhibitors and methodologies to re-balance the immuno suppressive tumor condition.

Bioethics
Analytic protocols of biomarkers
Case studies
Viral Mimicry of genes
Principle investigator
Viral Therapy
Viral-associated Cancers

Track 15: Cancer Pharmacology

Cancer pharmacology an association investigations of the major mechanism of signal transduction related with cell proliferation and apoptosis, the mechanism of activity of anti-neoplastic specialists, the outline and revelation of new medications, essential components of DNA repair and DNA harm resilience and the advancement of novel techniques for quality treatment. Cancer Pharmacology deals with the drugs used in cancer treatment, their mechanism of action, their side effects and their mode of exclusion. Combination of Drugs and their ability plays a key choice of research interest. Investigation determinations in tumour pharmacology take account of trainings of the simple instruments of indication transduction related with cell multiplying and apoptosis, the contrivances of achievement of anti-neoplastic agents, the scheme and finding of original drugs, simple contrivances of DNA repair and DNA impairment acceptance and the progress of fresh plans for gene therapy. Importance is hired on the account and classification of elementary signing machines that generate the marks of molecules used for cancer therapy and DNA damage and renovation apparatuses that pay to anti-neoplastic drug conflict. The rule of tyrosine kinases, treating of proto-oncogenes, parameter of minor GTPases and their effectors, cell-cycle-specific kinases and DNA repair gene products are actuality studied as possible marks or to improve the efficiency of present chemotherapeutic means. The part of growing elements in the movement of solid and hematopoietic tumors is presently studied; innovative receptors and signal transduction paths are being recognized in usual and malicious tissues.

Anti-Cancer drugs mechanism of action
Anti-Cancer drugs absorption and distribution
Clinical Toxicology
Pharmacokinetics
Pharmacodynamics
Genetic manipulation of cancer
Malignant transformation

Track 16: Cancer Nanotechnology

Cancer nanotechnology is a growth of treatment that offers some energizing potential consequences, counting the likelihood of obliterating malignancy growth with minor harm to wide-ranging tissue and organs, and additionally the detection and removal of diseased cells before they frame tumors. One treatment being operated which contains focused on chemotherapy that conveys a tumor-executing specialist called tumor rot factor alpha (TNF) to grow tumors. TNF is linked to a gold nanoparticle next to Thiol-derivatized polyethylene glycol (PEG-THIOL), which masks the TNF bearing nanoparticle from the indestructible framework. This approves the nanoparticle to course through the circulatory system without being assaulte

Chemo Drugs
Stealth Nanoparticles and Tumor Penetrating Peptides
Vector/Host Interaction
New Nanomaterials
Imaging and Theranostics
Early Diagnosis and Imaging
Advances in Nanotechnology

Track 17: Oncology Nursing Care

Oncology nursing care is also an significant feature in the treatment of cancer which encounters the several needs of oncology patients all through the time of their disease containing appropriate screenings, preventative practices, symptom managing, care to recollect as much normal functioning as possible, and supportive measures upon end of life. Nurses need progressive certifications and clinical experiences in oncology other than the typical bachelorette nursing program provides. They are in responsibility of charting patients who have introduced because of treatment reactions, and also evaluating patients, amid and post-chemotherapy. The oncology cultivate requisite to have the capability to comprehend pathology comes about and their suggestions, and have an inside and out learning of the normal symptoms of growth medicines. The oncology support should likewise consume her relational abilities to adjust in to the patient, surveying their comprehension of the malady and its procedure and also the patient's passionate state.

Cancer & lifestyle connection
Community oncology nursing
Preventive oncology
Nursing Management
Critical Care
Clinical Nursing

Track 18: Cancer Case reports

Cancer has a varied nature in relation to the organ specificity. Utmost cancers are a collection of more than a hundred diseases that multiply throughout time in any of the body’s tissues. Each type of cancer has its capabilities; the simple procedures that produce most cancers are pretty comparable in all sorts of the diseases. A case record is the detailed document of signs and symptoms, prognosis, therapies of the limited sufferers of positive clinical records with unique healing strategies. As about 7.6 million of latest instances of malignancy documented every year, 1/2 of them are from developing countries. Case reports want to be up to date from all the statistics from the beyond.

Clinical case reports
Rare Surgical Condition of a cancer case
Novel Surgical Procedure
Adverse Effects

Market Analysis Report

Cancer is one of the major problems across the globe and it is said to one of the reason in the increase of the death ratio in this century. As cancer is not a single disease, it is very wide range of diseases approx. 200 cancers related disease has been witnessed. As people monitored urbanization, inestimable treatments are now available against cancer i.e. chemotherapy, radiation therapy, surgery, hormonal therapy, certain therapies interconnected to biology comparable monoclonal antibody and immunotherapy. All variations of cancer involve in different kind of treatments originated on the kind of cancer, location, tumor grade, phase of cancer and even the state of the person as health wise. The mortality rate due to cancer can be condensed if the early detection of the disease is done so that it can be cured early. And different sort of advancements in various therapies is increasing due to the early detection, increase time duration of the treatments along with the effectiveness of it.

A committee is gathering for an enlightening and innovative conference on Oncologists Congress. This conference gives prospect for delegates from various Institutes, Universities with various Scientists, Researches, Industrialists in the field of cancer providing with various lectures, poster presentation, various workshops, along with varieties of programs for the participants of the conference across the globe. This is a platform in which every single person has chance to share his/her ideas in the particular topic or may be related and any idea can inspire the formation of any novel thing which could be beneficial for the human in different ways. We are inviting you in this conference, come and join us and spread key of knowledge to all. We look forward to meet you all in Baltimore, USA.

Market point of view

Due to extension in the treatment of cancer day by day, this contains various therapies which develop the rapid growth in the market, globally. The current analysis is reports of cancer diagnosis world wide of global market from 2015 to 2025 revenue. From the analysis, the market needed to reach at $ 22.10 billion by 2025 from $7.1 billion of 2015. From the global market of the cancer diagnostic, which able to bring change at fast rate by advancement in the techniques which relates the market? In 2017, the rate was $9.10 billion, and it should reach to $12.00 billion by 2019, by enlisting the compound yearly development rate (CAGR) of only 1.3 % since 2015-2019. And the increment of the market is relying on the increment of the revenue from $7.1 billion of 2015 to $ 22.10 billion of 2025 with the development rate of 5.5 %.